Reglan

Nationwide Reglan Lawsuit

Reglan, a drug used to treat the symptoms of diabetic gastroparesis, which include vomiting, nausea, heartburn, feeling of indigestion, persistent fullness after meals, and appetite loss, manufactured by Baxter Healthcare, has been linked to a serious side effect including the following: Tardive Dyskinesia, a neurological disorder which causes involuntary movements of the tongue, mouth, face, lips and sometimes arms, trunk or legs.

What is Reglan?

Reglan (Metoclopramide hydrochloride), manufactured by Baxter Healthcare and approved by the FDA in 2004, is used to treat nausea, vomiting, and heartburn caused by gastric reflux. The FDA approved Reglan to be used by patients for a term of 4-12 weeks. Continuous treatment beyond 12 weeks is not recommended, however, 1/3 of patients are being prescribed the medication for 12 months or greater. The extended use of Reglan has led to the development of Tardive Dyskinesia in 27-29% of long term use patients.

Reglan Side Effects

Below is a list of the most common side effects of Reglan.

• Tardive Dyskinesia
• Involuntary movements of the tongue, mouth, face, lips and sometimes arms, trunk or legs
• Neuroleptic Malignant Syndrome
• Death

Reglan Lawsuit - Your Legal Rights

If you or somebody you know has developed Tardive Dyskinesia, Neuroleptic Malignant Syndrome or is suffering from Reglan side effects, you should contact one our Reglan attorneys as soon as possible. Regardless of your situation, you are sure to have questions. The only way to get your questions answered is to learn your legal rights and that is where our Reglan lawyers come in.

An experienced Mass Tort law firm can answer your questions and provide you with a free case evaluation regarding the potential to seek financial recovery through litigation. While we understand that a financial recovery will not bring back a loved one or compensate for a lifelong disability, we also urge you to exercise your right to seek legal counsel regarding your potential Reglan lawsuit.